Goldman Sachs BDC, Inc. (NYSE:GSBD) Receives $9.75 Average Target Price from Analysts

Goldman Sachs BDC, Inc. (NYSE:GSBD) has earned a consensus recommendation of “Reduce” from the five analysts that are currently covering the firm, Marketbeat.com reports. Two research analysts have rated the stock with a sell recommendation and three have given a hold recommendation to the company. The average 12-month price objective among brokerages that have updated their coverage on the stock in the last year is $9.75.

Several brokerages have recently issued reports on GSBD. Lucid Cap Mkts raised Goldman Sachs BDC to a “hold” rating in a research report on Monday, December 15th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Goldman Sachs BDC in a report on Monday, December 29th. Zacks Research raised Goldman Sachs BDC from a “strong sell” rating to a “hold” rating in a research report on Thursday, November 13th. The Goldman Sachs Group initiated coverage on Goldman Sachs BDC in a research report on Monday, December 15th. They issued a “neutral” rating and a $10.50 price objective for the company. Finally, Wells Fargo & Company lowered their price objective on shares of Goldman Sachs BDC from $10.00 to $9.00 and set an “underweight” rating on the stock in a research note on Monday, November 10th.

Goldman Sachs BDC Trading Up 1.9%

Shares of GSBD stock opened at $9.52 on Friday. Goldman Sachs BDC has a 12 month low of $8.92 and a 12 month high of $13.44. The company has a quick ratio of 1.81, a current ratio of 1.81 and a debt-to-equity ratio of 1.27. The business’s 50 day moving average is $9.50 and its two-hundred day moving average is $10.18. The company has a market cap of $1.09 billion, a PE ratio of 8.21 and a beta of 0.62.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. Aspiriant LLC grew its stake in shares of Goldman Sachs BDC by 9.5% in the 2nd quarter. Aspiriant LLC now owns 11,500 shares of the financial services provider’s stock valued at $129,000 after purchasing an additional 1,000 shares during the period. Atria Wealth Solutions Inc. lifted its position in shares of Goldman Sachs BDC by 4.9% during the 2nd quarter. Atria Wealth Solutions Inc. now owns 22,052 shares of the financial services provider’s stock worth $254,000 after buying an additional 1,022 shares during the period. Oppenheimer & Co. Inc. boosted its stake in Goldman Sachs BDC by 4.0% in the 3rd quarter. Oppenheimer & Co. Inc. now owns 27,847 shares of the financial services provider’s stock valued at $283,000 after buying an additional 1,082 shares in the last quarter. IHT Wealth Management LLC boosted its stake in Goldman Sachs BDC by 5.7% in the 2nd quarter. IHT Wealth Management LLC now owns 21,647 shares of the financial services provider’s stock valued at $244,000 after buying an additional 1,173 shares in the last quarter. Finally, Ameriprise Financial Inc. grew its position in Goldman Sachs BDC by 1.4% in the third quarter. Ameriprise Financial Inc. now owns 100,190 shares of the financial services provider’s stock valued at $1,019,000 after acquiring an additional 1,397 shares during the period. Institutional investors and hedge funds own 28.72% of the company’s stock.

Goldman Sachs BDC Company Profile

Goldman Sachs BDC, Inc (NYSE: GSBD) is an externally managed, closed-end, non-diversified management investment company organized as a business development company (BDC) under the U.S. Investment Company Act of 1940. The company’s primary objective is to generate current income and capital appreciation through debt and equity investments in U.S. middle-market companies. It principally invests in senior secured loans, mezzanine debt, preferred equity and, to a lesser extent, common equity, focusing on sponsor-backed transactions and special-situation financings.

The fund is advised by affiliates of Goldman Sachs Asset Management’s Private Credit Group, leveraging the firm’s global research capabilities and risk management infrastructure.